HomeAbout UsContact Us1-800-688-2421
BioWorld
Advanced Search

User ID

Password

Forgot password

Remember my login



New User ?

Products & Services
BIOWORLD TODAY
BIOWORLD INSIGHT
BIOWORLD INTERNATIONAL
BIOTECH RESOURCES
MEDTECH RESOURCES
BIOWORLD ARTHRITIS REPORT 2009
BIOMATERIALS REPORT 2009
BIOTECHNOLOGY AND MEDICAL DEVICE VC DIRECTORY 2009
BIOWORLD PERSPECTIVES
AUDIO CONFERENCES
MEDICAL DEVICE DAILY
Untitled Document
BioWorld Stock Index
For the week ending 7/3/09
-2.74

AMEX Biotech Index
Close 7/3/09
664.54  -22.73

NASDAQ Biotech Index
Close 7/3/09
725.13  -20.21
Today's Issue of BioWorld Today

BioWorld Wire, powered by PR Newswire
Biotech news | Pharma news

Thursday, July 2, 2009

Today's Headlines

Elan's AD Drug Down, Not Out: J&J Pledges $1.5B in Venture

Johnson & Johnson plans to make a whopping $1.5 billion investment in Elan Corp. plc in exchange for a stake in Dublin-based Elan, in a deal that will transfer key Alzheimer's programs, including Phase III bapineuzumab, to the U.S. drugmaker. (BioWorld Today)

There's no Expiration on this Knowledge, but the Education Opportunity will Expire July 31!

Catch up on what you've missed for 40% off! This is your opportunity to get in the know and listen to noted speakers in the industry discuss current topics affecting your business today. BioWorld Today and Medical Device Daily offers this special rate through July 31, 2009. Click here and order now!

Arthritis Is Making a Killing in a Maturing Market

I well remember the day I ceded control of my spinal column. Years ago, I bent over at the waist with my daughter in one arm to pick up my house keys. I felt a disturbance in my lumbar force that felt like lava running down my spine. It was just my spine crying and giving me a preview of the abyss of suffering that I was to experience forevermore at the whim of my musculoskeletal system. As I fought blacking out, visions of my dad recurred with his admonition, "Bend with your knees — your waist is only good for holding up your pants!" It was too late. (BioWorld Perspectives)

UK Committing £150M to Grow Biotech Innovation, Start-ups

LONDON — The UK government is putting in £150 million (US$248 million) as a cornerstone investor in what it hopes will become a £1 billion fund for biotech and other high-tech start-ups over the next 10 years. (BioWorld International)


Comparative Effectiveness: Risks and Opportunities in the New Reimbursement Landscape—The 2009 stimulus bill has allocated $1.1 billion for comparative effectiveness research. CMS is in the first stages of a plan to make national coverage determinations based on outcomes evidence from competing treatments. In this 90-minute audio conference scheduled for July 9th, expert attorney Bernadette M. Broccolo provides insight on reimbursement strategies in this new environment. Click here for more details.

BioWorld Home   |   About BioWorld   |   Contact Us
Copyright Notices   |   Terms of Use   |   Privacy Statement